Jun 14, 2026 08:05AM
Jun 14, 2026 03:15AM
Jun 10, 2026 09:30AM
Jun 9, 2026 06:19PM
Jun 9, 2026 06:18PM
Jun 8, 2026 02:31PM
Jun 8, 2026 02:30PM Lilly's oral GLP-1 Foundayo (orforglipron) delivered superior A1C control and weight loss in three pivotal type 2 diabetes trials
Jun 8, 2026 02:56AM
Jun 7, 2026 11:00AM
Jun 6, 2026 02:53PM
Jun 6, 2026 02:30PM
Jun 4, 2026 08:03AM
Jun 2, 2026 09:30AM
Jun 2, 2026 09:30AM Lilly to spotlight growing hematology portfolio at 2026 European Hematology Association (EHA) Annual Meeting
Jun 1, 2026 02:53AM
May 31, 2026 11:21PM
May 31, 2026 08:01AM
May 28, 2026 01:00PM
May 28, 2026 01:00PM
May 28, 2026 06:47AM
May 28, 2026 06:45AM Foundayo and Zepbound now covered for millions of Americans
May 26, 2026 05:50AM
May 25, 2026 08:45AM
May 21, 2026 05:02PM
May 21, 2026 05:00PM
May 21, 2026 06:45AM
May 21, 2026 06:45AM
May 12, 2026 06:01PM Lilly reports weight maintenance with Foundayo and reduced-dose Zepbound
May 12, 2026 06:01PM
May 12, 2026 12:53PM
May 12, 2026 09:00AM
May 11, 2026 08:30AM
May 6, 2026 09:01AM
May 6, 2026 09:00AM
May 5, 2026 12:30PM Novo Nordisk reports Q1 earnings on Wednesday: Analysts flag key focus topics
May 4, 2026 09:27AM
May 4, 2026 08:57AM
May 4, 2026 08:44AM
Apr 30, 2026 09:23AM
Apr 30, 2026 07:21AM
Apr 30, 2026 06:45AM
Apr 24, 2026 06:28AM Eli Lilly & Co. (LLY) shares trade lower on weak Foundayo launch
Apr 23, 2026 08:40AM
Apr 23, 2026 06:15AM
Apr 17, 2026 09:57AM
Apr 17, 2026 08:14AM
Apr 16, 2026 11:07AM
Apr 16, 2026 06:45AM
Apr 16, 2026 06:45AM ACHIEVE-4, the longest Phase 3 study of Lilly's Foundayo (orforglipron) to date, reaffirmed its cardiovascular and overall safety profile as well as consistent improvements across key measures of card
Apr 15, 2026 09:39AM

322,995 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All